SDGR
NASDAQ HealthcareSchrodinger, Inc. - Common Stock
Health Information Services
Schrรถdinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrรถdinger, Inc. was incorporated in 1990 and is based in New York, New York.
๐ Market Data
| Price | $29.19 |
|---|---|
| Volume | 759,729 |
| Market Cap | 2.19B |
| Beta | 1.690 |
| RSI (14-Day) | 74.7 Overbought |
| 200-Day MA | $15.53 |
| 50-Day MA | $19.23 |
| 52-Week High | $31.59 |
| 52-Week Low | $10.95 |
| Forward P/E | -21.70 |
| Price / Book | 6.49 |
๐ฏ Investment Strategy Scores
SDGR scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (97/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ช Falling Knife (1/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find SDGR in your text
Paste any article, transcript, or post โ the tool will extract SDGR and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-09-24.